This page lists the SEC filings reported by New Leaf Ventures II, L.P..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2021-02-10 | New Leaf Ventures II, L.P. | Neuronetics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-13 | New Leaf Ventures II, L.P. | Principia Biopharma Inc. | 792,091 | 2.4% | EDGAR |
| SC 13G/A | 2020-02-13 | New Leaf Ventures II, L.P. | Neuronetics, Inc. | 1,039,285 | 5.6% | EDGAR |
| SC 13G | 2019-02-13 | New Leaf Ventures II, L.P. | Principia Biopharma Inc. | 2,216,799 | 9.3% | EDGAR |
| SC 13G | 2019-02-13 | New Leaf Ventures II, L.P. | Neuronetics, Inc. | 1,543,115 | 8.8% | EDGAR |
| SC 13G/A | 2017-08-21 | New Leaf Ventures II, L.P. | Oxford Immunotec Global PLC | - | - | EDGAR |
| SC 13G/A | 2017-07-06 | New Leaf Ventures II, L.P. | iRhythm Technologies, Inc. | - | - | EDGAR |
| SC 13D/A | 2017-03-28 | New Leaf Ventures II, L.P. | Versartis, Inc. | - | - | EDGAR |
| SC 13G | 2017-02-10 | New Leaf Ventures II, L.P. | iRhythm Technologies, Inc. | 1,813,978 | 8.2% | EDGAR |
| SC 13D/A | 2016-11-14 | New Leaf Ventures II, L.P. | Versartis, Inc. | 2,039,223 | 5.9% | EDGAR |
| SC 13D/A | 2015-04-14 | New Leaf Ventures II, L.P. | Versartis, Inc. | 2,039,223 | 7.0% | EDGAR |
| SC 13D/A | 2015-03-31 | New Leaf Ventures II, L.P. | MEI Pharma, Inc. | 2,100,000 | 5.9% | EDGAR |
| SC 13G/A | 2015-02-17 | New Leaf Ventures II, L.P. | CHIMERIX INC | - | - | EDGAR |
| SC 13D/A | 2014-11-19 | New Leaf Ventures II, L.P. | Durata Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2014-11-14 | New Leaf Ventures II, L.P. | Versartis, Inc. | 2,559,374 | 10.6% | EDGAR |
| SC 13D | 2014-04-07 | New Leaf Ventures II, L.P. | Versartis, Inc. | 3,371,930 | 14.5% | EDGAR |
| SC 13G | 2014-02-14 | New Leaf Ventures II, L.P. | CHIMERIX INC | 2,846,031 | 10.5% | EDGAR |
| SC 13G | 2014-02-14 | New Leaf Ventures II, L.P. | Oxford Immunotec Global PLC | 1,377,497 | 8.4% | EDGAR |
| SC 13G/A | 2013-12-27 | New Leaf Ventures II, L.P. | AMBIT BIOSCIENCES CORP | - | - | EDGAR |
| SC 13D/A | 2013-11-27 | New Leaf Ventures II, L.P. | MEI Pharma, Inc. | 3,780,475 | 16.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.